Diabetic neuropathy is the most debilitating complication that can cause significant morbidity and mortality in type 1 and type 2 diabetic patients. It is essential to detect symptoms or signs of diabetic neuropathy and determine risk factors as early as possible to implement interventions and to prevent further neuronal damage. The goal of SDG 3.4 is to reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being 3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
The relationship between healthy lifestyles and wellbeing, especially focused on women and pregnancy, continues to grow to understand and determine factors connected to chronic disease and to decrease them. Supports SDG target: 3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under‑5 mortality to at least as low as 25 per 1,000 live births
Elsevier,
Epigenetics of Stress and Stress Disorders
Volume 31 in Translational Epigenetics
2022, Pages 19-26
This chapter discusses the diagnosis of posttraumatic stress disorder (PTSD) according to the DSM-5 including diagnosis, measurement and assessment.
Elsevier,
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1 - Biology and Pathophysiology, 2022, Pages 257-285
This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the current view of the pathogenesis of HBV and HCV along with the report on their relation to the genotypes.
The sampling of interstitial fluid for real-time assay requires techniques that are sensitive, rapid, painless, minimally invasive and easy to use by patients. Microneedles can be incorporated into biosensors with subsequent use of these platforms for continuous monitoring or bio-chemical detection of analytes in the dermal interstitial fluid. Supports the goal of SDG 3.8 to achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.
Elsevier,
Diabetes Without Needles, Non-invasive Diagnostics and Health Management, 2022, Pages 27-92
Introduces diabetes including past, present, and future achievements in this field. The goal of SDG target 3.4.1 is to reduce the mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
This book chapter advances SDG 3 and 10 by presenting that (1) some of these depression scales do not correlate, suggesting that they assess different aspects of depression; (2) reports of depression in dementia vary based on depression in dementia scale used; and (3) severe memory impairment may impact the ability to assess depression in the patients using self-reports.
This book chapter advances SDG #3 and #10 by reviewing studies that showed treatments with multiple sessions of rTMS can influence cognition in people with neurodegenerative diseases. The chapter also considers novel therapeutic approaches based on the clinical use of rTMS.
Elsevier,
The COVID-19 Response: The Vital Role of the Public Health Professional, 2023, Pages 143-154
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by examining the role of social determinants and racism in COVID's inequitable impacts, the burnout of the workforce, and the politicization of the response as major factors that will influence the future of the public health system.
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial pharmaceutical applications of marine-derived compounds.
